Amplia Therapeutics Limited (ASX:ATX)
Australia
· Delayed Price · Currency is AUD 0.110
0.00 (0.00%)
At close: Mar 6, 2026
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 56.44 million as of March 6, 2026. Its market cap has increased by 79.60% in one year.
Market Cap
56.44M
Enterprise Value
27.66M
Revenue
5.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 56.44M, an increase of 63.61%. That is a compound annual growth rate of 4.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 57.16M |
| Entropy Neurodynamics | 53.31M |
| Proteomics International Laboratories | 52.03M |
| EZZ Life Science Holdings | 51.30M |
| Prescient Therapeutics | 63.09M |
| Avecho Biotechnology | 44.08M |
| Radiopharm Theranostics | 74.43M |
| Alterity Therapeutics | 76.13M |